Search by Drug Name or NDC
NDC 49483-0280-20 MUCOSA DM 20; 400 mg/1; mg/1 Details
MUCOSA DM 20; 400 mg/1; mg/1
MUCOSA DM is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TIME CAP LABORATORIES, INC.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 49483-0280-20Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 49483-0280-20Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 49483-0280 |
|---|---|
| Product ID | 49483-280_059abb7a-9449-e088-e063-6394a90a4b2d |
| Associated GPIs | 43997002520345 |
| GCN Sequence Number | 058386 |
| GCN Sequence Number Description | guaifenesin/dextromethorphan TABLET 400MG-20MG ORAL |
| HIC3 | B3T |
| HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
| GCN | 23807 |
| HICL Sequence Number | 000223 |
| HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR |
| Brand/Generic | Generic |
| Proprietary Name | MUCOSA DM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | GUAIFENESIN DEXTROMETHORPHAN |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20; 400 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Labeler Name | TIME CAP LABORATORIES, INC. |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49483-0280-20 (49483028020)
| NDC Package Code | 49483-280-20 |
|---|---|
| Billing NDC | 49483028020 |
| Package | 200 TABLET in 1 BOTTLE (49483-280-20) |
| Marketing Start Date | 2023-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |